adenosine diphosphate has been researched along with Vascular Diseases in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (58.33) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 1 (4.17) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Battastini, AMO; Bertoni, APS; Braganhol, E; de Campos, RP; Stefani, GP; Tamajusuku, ASK; Wink, MR | 1 |
| Alexander, RV; Askanase, AD; Conklin, J; Dervieux, T; Gartshteyn, Y; Geraldino-Pardilla, L; Kapoor, T; Khalili, L; Mor, A; Shimbo, D | 1 |
| Berger, JS | 1 |
| Harrison, P; Kunicki, TJ; Nugent, DJ; Rothwell, PM; Segal, HC; Syed, A; Williams, SA | 1 |
| Jørgensen, L | 1 |
| Glenn, JR; Heptinstall, S; Johnson, A; Myers, B; White, AE; Zhao, L | 1 |
| Heptinstall, S | 1 |
| Ferrario, E; Macchione, C; Molaschi, M; Pernigotti, L; Poli, L | 1 |
| D'Sa, S; Machin, SJ | 1 |
| Ishimoto, Y; Nakano, T | 1 |
| Burnstock, G | 1 |
| Hockaday, TD; Honour, AJ | 1 |
| Rosborough, TK; Swaim, WR | 1 |
| Ardlie, NG; Jakubowski, JA | 1 |
| Antonelli, M; Argentino, C; De Marinis, M; Prencipe, M | 1 |
| Born, GV | 1 |
| Flore, R; Nolfe, G; Pola, P; Tondi, P | 1 |
| Fitscha, P; Sinzinger, H; Tiso, B | 1 |
| Beilin, LJ; Kendrew, PJ; Strophair, JM; Sturm, MJ; Taylor, RR; Vandongen, R | 1 |
| Fitscha, P; Kaliman, J; Sinzinger, H | 1 |
| Besterman, EM; Gillett, MP | 1 |
| Hampton, JR; Nicholls, DG | 1 |
| Szanto, S | 1 |
| Douglas, AS; McNicol, GP; Turpie, AG | 1 |
3 review(s) available for adenosine diphosphate and Vascular Diseases
| Article | Year |
|---|---|
Oral Antiplatelet Therapy for Secondary Prevention of Acute Coronary Syndrome.
Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Administration, Oral; Aging; Blood Platelets; Cyclooxygenase 1; Diabetes Mellitus; Drug Administration Schedule; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Purinergic P2Y Receptor Antagonists; Receptor, PAR-1; Receptors, Purinergic P2Y12; Renal Insufficiency; Risk Factors; Secondary Prevention; Thrombin; Thromboxane A2; Time Factors; Vascular Diseases | 2018 |
Platelet behaviour and vascular disease.
Topics: Adenosine Diphosphate; Arachidonic Acids; Blood Platelets; Humans; Imidazoles; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Prognosis; Thrombosis; Vascular Diseases | 1980 |
Purinergic signaling and vascular cell proliferation and death.
Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Apoptosis; Cell Division; Endothelium, Vascular; Humans; MAP Kinase Signaling System; Muscle, Smooth, Vascular; Receptors, Purinergic P1; Receptors, Purinergic P2; Uridine Triphosphate; Vascular Diseases | 2002 |
1 trial(s) available for adenosine diphosphate and Vascular Diseases
| Article | Year |
|---|---|
Iloprost in peripheral vascular disease--platelet function and clinical outcome.
Topics: Adenosine Diphosphate; Blood Platelets; Cardiovascular Agents; Clinical Trials as Topic; Collagen; Epoprostenol; Humans; Iloprost; Male; Pain; Platelet Aggregation; Random Allocation; Vascular Diseases | 1987 |
20 other study(ies) available for adenosine diphosphate and Vascular Diseases
| Article | Year |
|---|---|
Biochemical analysis of ectonucleotidases on primary rat vascular smooth muscle cells and in silico investigation of their role in vascular diseases.
Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Antigens, CD; Aorta; Apyrase; Computer Simulation; GPI-Linked Proteins; Mice; Muscle, Smooth, Vascular; Nucleotides; Rats; Rats, Wistar; Vascular Diseases | 2020 |
Platelet bound complement split product (PC4d) is a marker of platelet activation and arterial vascular events in Systemic Lupus Erythematosus.
Topics: Adenosine Diphosphate; Autoantibodies; Autoimmunity; Biomarkers; Blood Platelets; Complement Activation; Complement C4; Disease Susceptibility; Humans; Lupus Erythematosus, Systemic; Platelet Activation; Platelet Aggregation; Platelet Count; Thrombosis; Vascular Diseases | 2021 |
Lack of association between aspirin responsiveness and seven candidate gene haplotypes in patients with symptomatic vascular disease.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Aspirin; Cohort Studies; Cyclooxygenase 1; Drug Resistance; England; Epinephrine; Female; Gene Frequency; Haplotypes; Humans; Integrin alpha2; Integrin beta3; Male; Membrane Glycoproteins; Membrane Proteins; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Polymorphism, Single Nucleotide; Receptors, Purinergic P2; Treatment Failure; Up-Regulation; Vascular Diseases; von Willebrand Factor | 2009 |
ADP-induced platelet aggregation in the microcirculation of pig myocardium and rabbit kidneys.
Topics: Adenosine Diphosphate; Animals; Blood Pressure; Coronary Vessels; History, 19th Century; History, 20th Century; Ischemia; Kidney; Microcirculation; Platelet Aggregation; Rabbits; Swine; Vascular Diseases | 2005 |
Leukocytosis, vascular disease, and adenine nucleotide metabolism.
Topics: Adenosine Diphosphate; Humans; Leukocytosis; Vascular Diseases | 2006 |
[ADP-induced platelet aggregation in vascular diseases of the elderly].
Topics: Adenosine Diphosphate; Aged; Aging; Arteriosclerosis; Cerebrovascular Disorders; Coronary Disease; Humans; Platelet Aggregation; Reaction Time; Vascular Diseases | 1981 |
Clopidogrel: a novel antiplatelet agent.
Topics: Adenosine Diphosphate; Aspirin; Clopidogrel; Humans; Ischemia; Myocardial Infarction; Platelet Aggregation Inhibitors; Ticlopidine; Vascular Diseases | 1999 |
Release of a product of growth arrest-specific gene 6 from rat platelets.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Blood Platelets; Collagen; Hemostasis; In Vitro Techniques; Intercellular Signaling Peptides and Proteins; Male; Proteins; Rats; Rats, Sprague-Dawley; Thrombin; Vascular Diseases | 2000 |
Increased sensitivity of in vivo platelet aggregation in rabbits after alloxan or streptozotocin.
Topics: Adenosine Diphosphate; Alloxan; Animals; Blood Glucose; Cerebral Cortex; Diabetes Mellitus, Experimental; Hyperglycemia; Insulin; Ketone Bodies; Male; Platelet Aggregation; Pyruvates; Rabbits; Streptozocin; Vascular Diseases | 1976 |
Acquired von Willebrand's disease, platelet-release defect and angiodysplasia.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Aged; Antigens; Blood Coagulation Tests; Blood Platelet Disorders; Blood Platelets; Collagen; Epinephrine; Factor VIII; Humans; Male; Platelet Aggregation; Vascular Diseases; von Willebrand Diseases | 1978 |
Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular disease.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Calcimycin; Collagen; Eicosanoic Acids; Epinephrine; Epoprostenol; Fatty Acids, Unsaturated; Humans; Platelet Aggregation; Rats; Vascular Diseases | 1979 |
[Platelet aggregation in vascular disease: possibilities and limits of Born's method].
Topics: Adenosine Diphosphate; Aged; Epinephrine; Female; Humans; Male; Methods; Middle Aged; Platelet Aggregation; Vascular Diseases | 1977 |
The thrombocyte membrane in circulatory diseases.
Topics: Adenosine Diphosphate; Blood Platelets; Cell Membrane; Erythrocyte Aggregation; Humans; Platelet Adhesiveness; Platelet Aggregation; Vascular Diseases | 1976 |
Rheological activity of propionyl L-carnitine.
Topics: Adenosine Diphosphate; Blood Viscosity; Carnitine; Humans; Pyrrolidines; Vascular Diseases | 1991 |
Whole blood aggregation and plasma lyso-PAF related to smoking and atherosclerosis.
Topics: Adenosine Diphosphate; Adult; Aged; Arteriosclerosis; Cell Aggregation; Collagen; Humans; Male; Middle Aged; Platelet Activating Factor; Smoking; Thromboxane B2; Vascular Diseases | 1989 |
Platelet sensitivity to antiaggregatory prostaglandins (PGE1,D2,I2) in patients with peripheral vascular disease.
Topics: Adenosine Diphosphate; Aged; Alprostadil; Blood Platelets; Diabetes Mellitus; Epoprostenol; Female; Humans; Hyperlipoproteinemias; Male; Middle Aged; Platelet Aggregation; Prostaglandin D2; Prostaglandins D; Prostaglandins E; Risk; Smoking; Vascular Diseases | 1985 |
Influence of lysolecithin on platelet aggregation initiated by 5-hydroxytryptamine.
Topics: Adenosine Diphosphate; Arteries; Chronic Disease; Epinephrine; Humans; In Vitro Techniques; Lysophosphatidylcholines; Male; Platelet Adhesiveness; Serotonin; Serotonin Antagonists; Vascular Diseases | 1973 |
Effect of detergents on platelet electrophoresis and aggregation, and the possible relation of plasma surface activity to thrombosis.
Topics: Adenosine Diphosphate; Arteries; Blood Platelets; Cell Movement; Cetylpyridinium; Detergents; Electrophoresis; Humans; Ions; Norepinephrine; Plasma; Platelet Adhesiveness; Surface Tension; Thrombosis; Vascular Diseases | 1972 |
Blood platelet behaviour in primary neuronal and vascular dementia.
Topics: Adenosine Diphosphate; Aged; Blood Platelets; Dementia; Electrophoresis; Female; Humans; Male; Nerve Degeneration; Vascular Diseases | 1972 |
Platelet electrophoresis: effect of defibrination by ancrod (Arvin).
Topics: Acute Disease; Adenosine Diphosphate; Anticoagulants; Blood Platelets; Electrophoresis; Fibrinogen; Humans; Norepinephrine; Plasminogen; Vascular Diseases; Venoms | 1972 |